Search International and National Patent Collections
Some content of this application is unavailable at the moment.
If this situation persists, please contact us atFeedback&Contact
1. (ES2386550) Derivados de piridazinilamina, el uso de los mismos en la preparación de inhibidores de picornavirus

Office : Spain
Application Number: 05812984 Application Date: 14.11.2005
Publication Number: 2386550 Publication Date: 22.08.2012
Publication Kind : T3
Prior PCT appl.: Application Number:CN2005001913 ; Publication Number:2007003077 Click to see the data
IPC:
C07D 401/12
C CHEMISTRY; METALLURGY
07
ORGANIC CHEMISTRY
D
HETEROCYCLIC COMPOUNDS
401
Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
02
containing two hetero rings
12
linked by a chain containing hetero atoms as chain links
CPC:
C07D 237/20
C07D 401/04
C07D 401/12
Applicants: INSTITUTE OF PHARMACOLOGY AND TOXICOLOGY ACADEMY OF MILITARY MEDICAL SCIENCES P.L.A. CHINA
Inventors: LI, Song
MI, Chunlai
ZHENG, Zhibing
ZHAO, Guoming
ZHOU, Xinbo
GONG, Zehui
Agents: Carpintero Carpintero Mario
Priority Data: 200510081813 30.06.2005 CN
Title: (ES) Derivados de piridazinilamina, el uso de los mismos en la preparación de inhibidores de picornavirus
Abstract: front page image
(EN) The present invention relates to substituted pyridazinylamine derivatives of the formula I or pharmaceutically acceptable salts or hydrates thereof, wherein the substituents are defined as in the description, their preparation process, pharmaceutical compositions comprising them, and uses of the said compounds as picorna virus inhibitors for prevention and/or treatment of diseases caused by picorna viruses.
(FR) La présente invention décrit des dérivés substitués de pyridazinylamine de formule I, ainsi que les sels et hydrates de qualité pharmaceutique desdits dérivés, leur méthode de synthèse, des préparations pharmaceutiques contenant lesdits composés, et leur emploi en tant qu'inhibiteurs des picornavirus dans le traitement prophylactique et thérapeutique de maladies virales induites par les picornavirus.
Also published as:
KR1020080045120EP1900735JP2008546814RU02380366US20080269232US20110059978
AU2005334058DK1900735IN636/DELNP/2008WO/2007/003077